Published in Gene Therapy Weekly, October 11th, 2001
The coating compound consists of a gelatinous substance combined with a photo-initiator called carboxylated camphorquinone, according to Yasuhide Nakayama, National Cardiovascular Center Research Institute, Japan, and coinvestigators.
"A few minutes of visible light irradiation of a stent after dip-coating of an aqueous solution of the photoreactive material resulted in the formation of a homogeneously crosslinked gelatinous layer on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.